Key result
Early ischemic evaluation within 90 days of new-onset heart failure diagnosis was associated with a modestly lower long-term mortality risk (HR 0.92) compared to no early evaluation.
Why the study?
Does early ischemic evaluation reduce long-term mortality in patients with new-onset heart failure without known coronary artery disease?
Does early ischemic evaluation reduce long-term mortality in patients with new-onset heart failure without known coronary artery disease?
Hazard Ratio: 0.92
Routine, reflexive ischemic evaluation for all patients with new-onset heart failure yields only modest survival associations, supporting current guidelines that recommend a selective, individualized approach to testing.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) conducted an editorial in New-onset heart failure (n=61,475). Early ischemic evaluation vs. No early ischemic evaluation was evaluated on Long-term mortality (HR 0.92). Early ischemic evaluation within 90 days of new-onset heart failure diagnosis was associated with a modestly lower long-term mortality risk (HR 0.92) compared to no early evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: